Maternal Interleukin-17 and disease activity influence pregnancy outcomes in women with psoriatic arthritis and ankylosing spondylitis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2393
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Maternal Interleukin-17 and disease activity influence pregnancy outcomes in women with psoriatic arthritis and ankylosing spondylitis ; volume:23 ; number:1 ; day:17 ; month:1 ; year:2023 ; pages:1-9 ; date:12.2023
BMC pregnancy and childbirth ; 23, Heft 1 (17.1.2023), 1-9, 12.2023
- Urheber
-
Girbash, Ehab F.
Abdelwahab, Shaimaa M.
Atef, Rehab M.
Sherif, Hala E.
Abdeldayem, Hussein M.
Atta, Doaa S.
Radwan, Ahmed M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12884-023-05364-4
- URN
-
urn:nbn:de:101:1-2023032509364566083989
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Girbash, Ehab F.
- Abdelwahab, Shaimaa M.
- Atef, Rehab M.
- Sherif, Hala E.
- Abdeldayem, Hussein M.
- Atta, Doaa S.
- Radwan, Ahmed M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Interleukin-17 inhibitors for the treatment of ankylosing spondylitis
Secular trends in sickness absence among Swedish patients with ankylosing spondylitis and psoriatic arthritis
Andersson lesion in ankylosing spondylitis
Comparative Pharmacoeconomic Effectiveness of Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis
Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Variants in RUNX3 contribute to susceptibility to psoriatic arthritis exhibiting further common ground with ankylosing spondylitis.
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19+ B cells in patients with ankylosing spondylitis
Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status
ANKHvariants associated with ankylosing spondylitis: gender differences
Interleukin-17 inhibitors for the treatment of ankylosing spondylitis
Secular trends in sickness absence among Swedish patients with ankylosing spondylitis and psoriatic arthritis
Andersson lesion in ankylosing spondylitis
Comparative Pharmacoeconomic Effectiveness of Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis
Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Variants in RUNX3 contribute to susceptibility to psoriatic arthritis exhibiting further common ground with ankylosing spondylitis.
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19+ B cells in patients with ankylosing spondylitis
Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status
ANKHvariants associated with ankylosing spondylitis: gender differences
Interleukin-17 inhibitors for the treatment of ankylosing spondylitis
Secular trends in sickness absence among Swedish patients with ankylosing spondylitis and psoriatic arthritis
Andersson lesion in ankylosing spondylitis
Comparative Pharmacoeconomic Effectiveness of Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis
Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Variants in RUNX3 contribute to susceptibility to psoriatic arthritis exhibiting further common ground with ankylosing spondylitis.
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19+ B cells in patients with ankylosing spondylitis
Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status